Alpix Shares Early Beta Insights on AI-Assisted Trading and On-Chain Perpetuals Platform 
Heavyweight Endorsement from Top-tier Cornerstone Investors! Sigenergy (06656.HK) Launches IPO: Led by Temasek and Goldman Sachs, the AI Energy Storage Leader Ignites Hong Kong’s New Stock Frenzy 
Shoucheng Holdings (0697.HK) Combines Dividends and Share Buybacks in Tandem, Returning Approximately HK$6.877 Billion to Shareholders Over Eight Years 
Formerra Announces Global Price Increase 
U.S. Polo Assn. and ESPN Champion the Iconic USPA Gold Cup at the USPA National Polo Center, Hosted by Legendary Commentator Chris Fowler Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk
New collaboration increases access to genetic testing and can help identify patients with a high-risk…
Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk
New collaboration increases access to genetic testing and can help identify patients with a high-risk…
Independent Panel of Renowned Pediatric Endocrinologists to Discuss Pediatric Growth Hormone Deficiency and the Therapeutic Landscape
Virtual Webinar to be held September 5, 2023, at 11:00 AM Eastern Time AUSTIN, Texas,…
Independent Panel of Renowned Pediatric Endocrinologists to Discuss Pediatric Growth Hormone Deficiency and the Therapeutic Landscape
Virtual Webinar to be held September 5, 2023, at 11:00 AM Eastern Time AUSTIN, Texas,…
Ashvattha Therapeutics Presents Promising Preclinical Data on New Dendranib Nanomedicine Candidate ASH41020 at the 16th International Society of Neuroimmunology Congress (ISNI)
Data demonstrated that ASH41020, a novel CSFR1 tyrosine kinase inhibitor ‘dendranib’, directs macrophage polarization toward…
Ashvattha Therapeutics Presents Promising Preclinical Data on New Dendranib Nanomedicine Candidate ASH41020 at the 16th International Society of Neuroimmunology Congress (ISNI)
Data demonstrated that ASH41020, a novel CSFR1 tyrosine kinase inhibitor ‘dendranib’, directs macrophage polarization toward…
Shockwave Medical to Participate in Upcoming Investor Conferences
SANTA CLARA, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a…
SELLAS Life Sciences Independent Data Monitoring Committee Recommends Galinpepimut-S REGAL Trial to Continue Without any Modifications
REGAL Interim Analysis Expected by Late 2023/Early 2024 Enrollment Expected to be Completed in Q4…
Shockwave Medical to Participate in Upcoming Investor Conferences
SANTA CLARA, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a…
SELLAS Life Sciences Independent Data Monitoring Committee Recommends Galinpepimut-S REGAL Trial to Continue Without any Modifications
REGAL Interim Analysis Expected by Late 2023/Early 2024 Enrollment Expected to be Completed in Q4…
Reflect Scientific Secures $200,000 Order from Prominent Bio-Pharma Client for Blast Freezers
OREM, Utah, Aug. 22, 2023 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a leading…
Longeveron Rights Offering Subscription Period Begins
MIAMI, Aug. 22, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) (“Longeveron” or…
Reflect Scientific Secures $200,000 Order from Prominent Bio-Pharma Client for Blast Freezers
OREM, Utah, Aug. 22, 2023 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a leading…
Longeveron Rights Offering Subscription Period Begins
MIAMI, Aug. 22, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) (“Longeveron” or…
PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan
REDWOOD CITY, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) — PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT…
PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan
REDWOOD CITY, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) — PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT…
Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201
– Agreement expansion facilitates preparation for commercial readiness for CABA-201, enabling treatment of patients in…
Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201
– Agreement expansion facilitates preparation for commercial readiness for CABA-201, enabling treatment of patients in…
60 Degrees Pharmaceuticals Receives Additional U.S. Patent Covering Tafenoquine for Prevention of Plasmodium Falciparum Malaria
60P was awarded additional U.S. patent protection to further solidify its exclusive rights through 2035…
60 Degrees Pharmaceuticals Receives Additional U.S. Patent Covering Tafenoquine for Prevention of Plasmodium Falciparum Malaria
60P was awarded additional U.S. patent protection to further solidify its exclusive rights through 2035…